Skip to Content
Kitov Announces Dosing of First Patient in Phase 1/2 Clinical Trial of NT219 in Advanced Cancer Patients
Thinking about buying stock in Gevo Inc, Kitov Pharma, Plug Power, American Airlines, or Vuzix Corp?
Kitov Pharma Receives Notice of Intention to Grant Two Patents in China Covering Company’s Lead Oncology Assets, CM24 and NT219
Kitov Pharma Announces ADS Ratio Change
Kitov Pharma Provides Corporate Update and Reports First Half 2020 Financial Results
Kitov Announces Initiation of Phase 1/2 Clinical Trial of NT219 in Advanced Cancer Patients
Kitov Pharma Receives Notice of Intention to Grant a European Patent Covering CM24, its anti-CEACAM1 Antibody
Thinking about buying stock in Seanergy Maritime Holdings, Kitov Pharma, Gevo Inc, Vivint Solar, or Hepion Pharmaceuticals?
Kitov Pharma Issues CEO Shareholder Letter Providing Business Update
Thinking about buying stock in T2 Biosystems, Ameresco Inc, Xeris Pharmaceuticals, Blink Charging, or Kitov Pharma?